Oxford to resume trials of its vaccine candidate
Headline:
167 AL leaders and activists surrender in Jashore court, 42 get bail
Fire guts 8 shops in Rajshahi
Two agreements worth $900 million signed with World Bank
Prof Shahidullah elected president of Child Health Foundation

Oxford to resume trials of its vaccine candidate

Oxford to resume trials of its vaccine candidate


Oxford University announced to resume the trials of coronavirus vaccine candidate, that it is developing with pharmaceutical company AstraZeneca, after a disruption over the reported effect in a patient. 

The university authorities said such side effects are not totally unexpected, reports AP. 

“In large trials it is expected that some participants will become unwell and every case must be carefully evaluated to ensure careful assessment of safety," it added. 

According to the university, globally some 18,000 individuals have received study vaccines as part of the trial.

It wouldn't disclose the medical information about the illness for reasons of participant confidentiality but says it is "committed to the safety of our participants and the highest standards of conduct in our studies and will continue to monitor safety closely."

Also read: Coronavirus vaccine to be available by end of year: Chinese company

Health experts say pauses in drug trials are commonplace to ensure safety and effectiveness.
 

Subscribe UNB YouTube Channel
coronavirus coronavirus vaccine COVID-19 Oxford University vaccine trial Covid-19 deaths in Bangladesh